[Adjuvant chemotherapy for high-risk endometrial carcinoma].
Komatsu
Masaaki
M
Department of Obstetrics and Gynecology, Graduate School of Biomedical Sciences, Hiroshima University.
Takehara
Kazuhiro
K
Fujii
Tsuneo
T
D000290:Adnexa Uteri / Q000601:surgery; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D016889:Endometrial Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011182:Postoperative Care; D011379:Prognosis; D012306:Risk; D012307:Risk Factors
D000970:Antineoplastic Agents